Skip to main content

Expert Insights

First Report Managed Care
Beth Roberts, senior vice president, commercial business at Harvard Pilgrim Health Care, discusses the importance of communicating with members what is available to them through their plan, and how population health management is key in delivering quality care.
Annals of Long-Term Care
Michael Gordon, MD, MSc, FRCPC, geriatrician, recalls his time spent as a patient in a palliative care program and what this experience taught him about caring for patients in these programs.
First Report Managed Care
With technology constantly evolving, the health care industry pushes forward developing new ways to look at and assess population health so that patients, providers, and payers alike will see improved outcomes and reduced costs.
Annals of Long-Term Care
Ilene Warner-Maron, PhD, reviews a recent study and explains why this research should prompt long-term care providers to address the utility of CPR in their facilities.
Annals of Long-Term Care
In this article, authors discuss the risks and benefits associated with anticoagulation in older patients with AF.
First Report Managed Care
Our experts analyze pending legislation, branded drug price increase trends, the real impact of the record number of generic drug approvals, and the value of presidential executive action.
Pharmacy Learning Network
Mark Munger, PharmD, discusses the question, “Are we maintaining professional competency for the efforts, money, and time we spend in CE activities?”
Pharmacy Learning Network
Michael Cawley, PharmD, explains why he believes a recently approved diagnostic test has enormous potential for use.
Pharmacy Learning Network
At the end of 2019, a case was filed by a pharmacist against his former employer, alleging that he was fired in retaliation for refusing to fill a pain medication prescription for a patient who had recently been arrested on drug charges.
Pharmacy Learning Network
The Model Pharmacy Practice Act (PPA) allows a pharmacist only to practice within established standards of practice. Innovation in pharmacy practice is therefore restricted. In this commentary, Mark Munger, PharmD, explains why he believes it is time to rethink the prescriptive nature of the PPA.
Back to Top